Demographics, Comorbidity, Treatment, Healthcare Resource Utilization, and Costs Analysis of Hidradenitis Suppurativa in Dubai
HS is well-documented disease in Dubai claims data and is associated with significant morbidity and healthcare costs. This sheds light on the high burden of HS and should trigger increased awareness as well as new disease management interventions. Newer therapies such as biologics should play a role in the management of HS in the UAE. .
Authors
- Kumaresan Subramanyam
- Ashok Natarajan
- Badarinath Chickballapur Ramachandrachar (ORCID: https://orcid.org/0000-0001-9965-1492)
- Falk G. Bechara (ORCID: https://orcid.org/0000-0003-0418-521X)
- Ahmed Reda (ORCID: https://orcid.org/0000-0002-0470-9645)
- Samir Hantirah
- Anwar Al Hammadi
- Amal Masalmeh
- Mohamed Farghaly
- Dayane Daou
- Saad Ehab
Institutions
- American University in Dubai (AE)
- Dubai Hospital (AE)
- IQVIA (United Kingdom) (GB)
- IQVIA (India) (IN)
- Mohammed Bin Rashid University of Medicine and Health Sciences (AE)
- Mediclinic City Hospital (AE)
- University Dermatology (US)
- St. Josef-Hospital (DE)
- American College of Dubai (AE)
- Dubai Medical College (AE)
- University of Modern Sciences (AE)
- Dubai Pharmacy College (AE)
Publication Details
- Journal
- Dermatology
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1159/000545025
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00